Atorvastatin decreased plasma lysophosphatidic acid level in patients with ischemic stroke

来源 :中国脑血管病大会2013 | 被引量 : 0次 | 上传用户:bqayxgflx1
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective:Lysophosphatidic acid (LPA) is released from activated platelets.Statins are the commonly used anti-atherosclerotic drug.The purpose of this study is to observe whether atorvastatin could decrease the plasma LPA levels in ischemic stroke patients.Methods:A total of 386 subjects,including the 247 ischemic stroke cases and 139 healthy controls,were enrolled in this study.The 247 ischemic stroke cases were divided into Group A (n=109) and Group B (n=138) who had and had not received atorvastatin treatment before a stroke respectively.The plasma LPA levels of all the subjects were measured using chromatography.Results:There was significant diffidence in the LPA levels between cases and controls (3.22+1.51 μmol/L vs.1.83+1.07 μmol/L,p<0.01).The plasma LPA level in Group A was lower than that of Group B (2.66+1.23 μmol/L vs.3.83+1.14 μmol/L,p<0.01).Atorvastatin (20mg/ d) significantly reduced LPA levels in ischemic stroke patients (n=138) compared with that before atorvastatin administration (1.96+0.87 μmol/L vs.3.83+1.14 μmol/L,p<0.01).However,the LPA levels re-elevated after atorvastatin withdrawl for one month.Atorvastatin could decrease the plasma LPA levels in patients with ischemic stroke,which providing a better understanding of how statins protect against ischemic stroke.Conclusion:It is plausible to speculate that statins might have an effect of anti platelet activation.
其他文献
目的 评估微型钢板内固定治疗断指再植后骨不连的疗效 方法收 集2009 年至2012 年因断指再植后出现指骨骨不连病例12 例,均为完全离断.12 例均行切开复位内固定术,术中清理骨不连断端嵌压的软组织,疏通髓腔,复位.对于存在明显骨缺损的采用自体骨植骨.12 例均采用AO 微型钢板固定,1 例附加自体骨植骨.结果 术后10 例患者均获得2-24 个月的随访,平均10.5 月.骨不连全部愈合,愈合
目的:人尿源性干细胞( human urine-derived stem cells,hUSCs) 是从尿液中分离出的多能干细胞,获取过程快捷且安全无创.我们已经证实hUSCs 与间充质干细胞相似的特性,膜表面标志物表达情况一致,具有成骨、成软骨、成脂肪的定向分化潜能.通过体外诱导,hUSCs 能够分化为神经细胞,表达神经干细胞、神经元以及胶质细胞的标志物.但是,hUSCs 是否能够在体内经过微环
Fibula plays an important role in distraction osteogenesis using Ilizarovexternal fixator.We tried to determine the underlying mechanisms that causedearly consolidation of the fibula.
会议
Background Radiographic measurements are typically used in achondroplasia (ACH) during correction of lower limb alignment.However,reliabilities for the measurements on weightbearing radiographs of the
会议
目的:本研究拟建立脊髓缺血再灌注损伤的动物模型,选用氢盐水对兔进行腹腔注射治疗,通过检测清除自由基、抑制神经细胞凋亡和减轻炎症反应等方面相关指标,探讨氢盐水对脊髓缺血再灌注损伤的保护作用机制.方法:Zivin 法制备兔脊髓缺血再灌注损伤模型,将30 只新西兰大白兔分为3 组:A 组(假手术组10 只)、B 组(对照组10只)、C 组(氢盐水治疗组10 只).
会议
The regenerative treatment of osseous defects is a formidable challenge inorthopedic surgery.In the present study,a novel biomimetic compositescaffold,here called nano-hydroxyapatite/poly-ε-caprolacto
[目的]比较分析位于基底节区不同直径的急性单灶脑梗死患者临床特点及梗死灶形成的可能机制.[方法]回顾性分析发病24 h 内梗死灶位于基底节区的急性单灶脑梗死患者144 例,发病72h 内完成头、颈部MRI+MRA.根据弥散加级成像上梗死灶最大直径分成三组:(1)腔隙组(LI 组,n = 60,病灶直径< 1.5 cm);(2)中等直径梗死组(M 组,n = 60,病灶直径1.5~3 cm);(3)
会议
本文主要针对2012年个主要医学杂志如新英格兰医学杂志评选出的有关脑卒中方面的临床研究进展,和今年近期的一些重要临床研究及2013年1月31日美国AHA/ASA在线发布了新的急性缺血性卒中早期管理指南的一些修改亮点做一背景分析和报道,以提高同道及时掌握最新的卒中临床研究的动态及进展.
会议
Background:To compare the efficacy of intravenous (Ⅳ) combination low-dose Tissue-type plasminogen activator (t-PA) and urokinase (UK) versus classical IV t-PA or UK alone for acute ischemic stroke (A
会议
目的:静脉rt-PA 溶栓治疗是经循证医学证明缺血性卒中超早期最有效的治疗药物.rt-PA 的疗效有时间依赖性,2013AHA/ASA 急性缺血性卒中早期管理指南要求患者到院至rt-PA 溶栓治疗时间(door-to-needle time,DNT)应控制在60 分钟以内(IA 证据).一个高效有序的急诊溶栓流程有助于减少院内延误.因此,华山医院于2011 年7 月启动了溶栓流程的优化.方法:20
会议